nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
|
Kanda, Tatsuo |
|
|
13 |
6 |
p. 649-661 |
artikel |
2 |
Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis
|
Liu, Bin |
|
|
13 |
6 |
p. 757-765 |
artikel |
3 |
Cellular and functional loss of liver endothelial cells correlates with poor hepatocyte regeneration in acute-on-chronic liver failure
|
Shubham, Smriti |
|
|
13 |
6 |
p. 777-787 |
artikel |
4 |
Circulating tumor cells are associated with poor outcomes in early-stage hepatocellular carcinoma: a prospective study
|
Ha, Yeonjung |
|
|
13 |
6 |
p. 726-735 |
artikel |
5 |
Clinical and morpho-molecular classifiers for prediction of hepatocellular carcinoma prognosis and recurrence after surgical resection
|
Zhang, Xiuming |
|
|
13 |
6 |
p. 715-725 |
artikel |
6 |
Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia–Pacific region
|
Chen, Tao |
|
|
13 |
6 |
p. 695-705 |
artikel |
7 |
Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update
|
Sarin, Shiv Kumar |
|
|
13 |
6 |
p. 826-828 |
artikel |
8 |
Epidemiology and clinical course of primary biliary cholangitis in the Asia–Pacific region: a systematic review and meta-analysis
|
Zeng, Na |
|
|
13 |
6 |
p. 788-799 |
artikel |
9 |
Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift
|
Liaw, Yun-Fan |
|
|
13 |
6 |
p. 665-673 |
artikel |
10 |
Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9–12 years) and adolescents
|
El-Araby, Hanaa A. |
|
|
13 |
6 |
p. 706-714 |
artikel |
11 |
Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9–12 years) and adolescents
|
El-Araby, Hanaa A. |
|
|
13 |
6 |
p. 706-714 |
artikel |
12 |
Hepatocellular carcinoma and non-alcoholic fatty liver disease
|
Golabi, Pegah |
|
|
13 |
6 |
p. 688-694 |
artikel |
13 |
MicroRNA-744/transforming growth factor β1 relationship regulates liver cirrhosis
|
Ren, Shuang |
|
|
13 |
6 |
p. 814-825 |
artikel |
14 |
Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis
|
Wang, Qianyi |
|
|
13 |
6 |
p. 766-776 |
artikel |
15 |
Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis
|
Li, Chao |
|
|
13 |
6 |
p. 736-747 |
artikel |
16 |
Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease
|
Eslam, Mohammed |
|
|
13 |
6 |
p. 662-664 |
artikel |
17 |
Sarcopenia and fatty liver disease
|
Kim, Jung A. |
|
|
13 |
6 |
p. 674-687 |
artikel |
18 |
Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study
|
Iino, Chikara |
|
|
13 |
6 |
p. 748-756 |
artikel |
19 |
Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial
|
Kumar, Manoj |
|
|
13 |
6 |
p. 800-813 |
artikel |